Volume 16, Number 2—February 2010
Lymphocytic Choriomeningitis Virus Meningitis, New York, NY, USA, 2009
We describe a case of lymphocytic choriomeningitis virus (LCMV) meningitis in a New York, NY, resident who had no apparent risk factors. Clues leading to the diagnosis included aseptic meningitis during winter and the finding of hypoglycorrachia and lymphocytosis in the cerebrospinal fluid. LCMV continues to be an underdiagnosed zoonotic disease.
Lymphocytic choriomeningitis virus (LCMV) belongs to the family Arenavirus and has been found in Europe, the Americas, Australia, and Japan. Arenaviruses are typically associated with rodents, which can become chronically infected. The viruses are zoonotic and transmissible to man. LCMV is primarily maintained in the common house mouse (Mus musculus and M. domesticus), but has also been reported among pet and research rodents, including hamsters and guinea pigs (1). The prevalence of LCMV in wild mice in the United States ranges between 3.9% and 13.4% (2). Human cases demonstrate a fall-to-winter predominance corresponding to the movement of rodents indoors (1). Limited data are available on human infections but serologic studies in Washington, DC, Baltimore, Maryland, and Birmingham, Alabama, identified evidence of previous infections among 2%–10% of the population sampled (3). A study in a Washington, DC, military base found that 8%–11% of patients having a febrile neurologic illness between 1941 and 1958 were seropositive for LCMV(4)
Transmission occurs by inhalation (aerosol and droplet), fomites, or direct contact with excreta or blood from infected rodents. Human-to-human transmission has been reported during pregnancy from infected mothers to the fetus (5) and through solid organ transplantation (6). The incubation period is 1–2 weeks. Infections in persons with an intact immune system are often asymptomatic or result in a mild self-limiting illness including fever, chills, myalgia, and headache. Photophobia, anorexia, testicular or parotid pain, pharyngitis, and cough have also been noted (1). Leukopenia, thrombocytopenia, and mild liver function abnormalities are common and may last 1–3 weeks. Central nervous system invasion is seen only in a few patients either after an initial febrile illness or, less commonly, without any early symptoms. During this neurologic phase, most patients have aseptic meningitis and a peripheral leukocytosis (1). Cerebrospinal fluid (CSF) leukocyte cell counts often exceed 1,000/μL, and glucose levels are low. Infection is rarely fatal, although ascending paralysis, transverse myelitis, or encephalitis may develop (1).
Critical or even fatal outcomes from LCMV are usually associated with transplacental infections, and, more recently, solid organ transplantation. Congenital LCMV can result in hydrocephalus, chorioretinopathy, macrocephalopathy, or microcephalopathy and can mimic the classic TORCH (toxoplasmosis/Toxoplasma gondii, other infections, rubella, cytomegalovirus, herpes simplex virus) pathogens. In 1 study of 26 infants with congenital LCMV, 9/26 (35%) died and 10/16 (63%) survivors had severe neurologic sequelae (7). Transplacental infection presumably occurs after maternal viremia during the first and second trimesters (8). In 2003 and 2005, the first reports of infection after solid organ transplantation were reported in which 7 of 8 patients receiving LCMV infected organs, kidney, liver, and lung, died (6). Therapy for LCMV is supportive, although limited data support the use of ribavirin in immunosuppressed patients. We report a case of meningitis caused by LCMV in New York City.
A 49-year-old man (taxi driver) sought treatment during the winter of 2009. He had a 7-day history of fever, chills, headache, nausea, vomiting, neck rigidity, generalized weakness, and paresthesias in his fingers. He denied recent travel or exposure to sick contacts. Medical history included a corneal transplant the previous year. His temperature when admitted was 37.5°C. Physical examination identified nuchal rigidity but was otherwise unremarkable. CSF showed leukocytes 871 cells/μL; erythrocytes 2 cells/μL, with 93% lymphocytes and 7% monocytes; glucose 32 mg/dL (serum glucose 93 mg/dL); and protein 185 mg/dL. Results of a computerized axial tomography scan of the brain and chest radiograph were unremarkable. A complete blood count and results of serum chemical tests and liver function tests were unremarkable. Blood cultures yielded no growth. CSF cultures for bacterial, fungal, and mycobacterial organisms were negative. Results for syphilis rapid plasma reagin, cryptococcal antigen, and HIV testing were negative.
Because of the patient’s hypoglycorrachia, pronounced CSF leukocytosis, and negative CSF cultures, acute infection with LCMV was considered. Serum tested at a commercial laboratory was positive for LCMV (immunoglobulin [Ig] G titer >256 (reference <16) and IgM titer 80 (reference <20) by immunofluorescence assay. CSF collected on day 1 and serum collected on days 7 and 15 was tested for LCM antibodies by the Centers for Disease Control and Prevention’s Special Pathogens Branch using ELISA. CSF and serum were both IgM and IgG positive and a 4-fold rise in acute-phase and convalescent-phase serum titers indicated the patient had a recent infection with LCMV (Table). The patient improved with supportive care, recovered fully, and was discharged on day 12.
The incidence rate of LCMV infection in New York City is unknown. The disease is likely underdiagnosed because only a limited number of commercial laboratories offer LCMV testing. Diagnosed cases of LCMV are often identified because they are part of a larger outbreak. Since 1960, only 7 cases have been reported in the literature (8,9); all but 2 had had contact with rodents. Several large outbreaks have been reported, often associated with pet hamsters or laboratory mice or hamsters; 1 outbreak had >236 human cases (8). A total of 54 cases of congenital LCMV are cited in the literature, 34 since 1993 (5).
Our patient denied both hamster and mouse exposure. His corneal transplant had occurred >1 year before, and was unlikely to be the source of infection. A definitive diagnosis was difficult, but testing by Centers for Disease Control and Prevention confirmed the diagnosis.
New York City Health Department officials attempted an investigation of the patient’s home and surroundings to look for evidence of rodents or rodent excreta, but were unable to do so due to the patient’s noncompliance. Several clues have assisted clinicians in the identification of patients with acute LCMV infection: 1) aseptic meningitis or encephalitis during the fall–winter season, 2) a febrile illness followed by brief remission before onset of neurologic illness, and 3) CSF with a lymphocytosis and hypoglycorrachia. Patients with suspected LCMV should be asked about potential rodent exposure (1). Patients with a history of organ transplantation within the preceding 3 months should be fully evaluated to determine whether infected organs were the source of LCMV.
We recommend enzyme immunoassay-based testing of CSF and serum when LCMV is considered. Public health surveillance, rodent control, healthcare provider education, and improved laboratory testing can enhance recognition of illness.
Health departments should consider making LCMV a reportable condition, and, if aseptic meningitis is reportable, questions should be added to case investigation forms regarding rodent exposure. LCMV was made reportable in New York City in 2009. Only with a better understanding of the true incidence of LCMV will authorities be able to enact measures to better prevent and control this disease in the vulnerable sections of our society.
Dr Asnis is director of infectious diseases at Flushing Hospital Medical Center, Flushing, New York, and clinical assistant professor in medicine at Cornell University Medical College. She helped identify the initial cases of West Nile virus encephalitis in the United States. Her research interests include neurologic infections, West Nile virus, tropical medicine, and HIV.
We thank Kirsten St George for providing assistance in PCR of CSF, Ellen Lee for consultation, and Robin Dornbaum for assistance with conducting a search of the medical literature.
- Peters CJ. Arenaviruses. In: Clinical virology. Richman DD, Whitley RJ, Hayden FG, editors. Washington: American Society of Microbiology Press; 2009. p. 1009–29.
- Childs JE, Glass GE, Korch GW, Ksiazek TG, Leduc JW. Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore. Am J Trop Med Hyg. 1992;47:27–34.
- Park JY, Peters CJ, Rollin PE, Ksiazek TG, Katholi DR, Waites KB, Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am J Trop Med Hyg. 1997;57:37–41.
- Meyer HM Jr, Johnson RT, Crawford IP, Dascomb HE, Rogers NG. Central nervous system syndromes of viral etiology: a study of 713 cases. Am J Med. 1960;29:334–47.
- Jamieson DJ, Kourtis AP, Bell M, Rasmussen SA. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol. 2006;194:1532–6.
- Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med. 2006;354:2235–49.
- Wright R, Johnson D, Neumann M, Ksiazek TB, Rollin P, Keech RV, Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics. 1997;100:E9.
- Gregg MB. Recent outbreaks of lymphocytic choriomeningitis in the United States of America. Bull World Health Organ. 1975;52:549–52.
- Sosa LE, Gupta S, Juthani-Mehta M, Hadler JL. Meningitis in a college student in Connecticut, 2007. J Am Coll Health. 2009;58:12–4.
Suggested citation for this article: Asnis DS, Muana O, Kim DG, Garcia M, Rollin PE, Slavinski S. Lymphocytic choriomeningitis virus meningitis, New York, NY, USA, 2009. Emerg Infect Dis [serial on the Internet]. 2010 Feb [date cited]. Available from http://wwwnc.cdc.gov/eid/article/16/2/09-1347
- Page created: December 13, 2010
- Page last updated: December 13, 2010
- Page last reviewed: December 13, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)